000 | 01872 a2200541 4500 | ||
---|---|---|---|
005 | 20250516070728.0 | ||
264 | 0 | _c20130207 | |
008 | 201302s 0 0 eng d | ||
022 | _a1525-6014 | ||
024 | 7 |
_a10.3109/01480545.2011.638927 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Jue-Long | |
245 | 0 | 0 |
_aEffect of celecoxib on Ca(2+) handling and viability in human prostate cancer cells (PC3). _h[electronic resource] |
260 |
_bDrug and chemical toxicology _cOct 2012 |
||
300 |
_a456-62 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 |
_aCalcium Channels, L-Type _xmetabolism |
650 | 0 | 4 | _aCelecoxib |
650 | 0 | 4 |
_aCell Death _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aEndoplasmic Reticulum _xmetabolism |
650 | 0 | 4 |
_aFluorescent Dyes _xchemistry |
650 | 0 | 4 |
_aFura-2 _xchemistry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPhospholipases A2 _xmetabolism |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aPyrazoles _xadministration & dosage |
650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
700 | 1 | _aLin, Ko-Long | |
700 | 1 | _aChou, Chiang-Ting | |
700 | 1 | _aKuo, Chun-Chi | |
700 | 1 | _aCheng, Jin-Shiung | |
700 | 1 | _aHsu, Shu-Shong | |
700 | 1 | _aChang, Hong-Tai | |
700 | 1 | _aTsai, Jeng-Yu | |
700 | 1 | _aLiao, Wei-Chuan | |
700 | 1 | _aLu, Yi-Chau | |
700 | 1 | _aChen, I-Shu | |
700 | 1 | _aLiu, Shuih-Inn | |
700 | 1 | _aJan, Chung-Ren | |
773 | 0 |
_tDrug and chemical toxicology _gvol. 35 _gno. 4 _gp. 456-62 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/01480545.2011.638927 _zAvailable from publisher's website |
999 |
_c21390639 _d21390639 |